We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The federal Competition Bureau will study Canada's generic pharmaceutical industry this year to assess whether Canadians are reaping enough benefits from cheaper copy-cat drugs.
Federal health officials cautioned women Friday that use of a GlaxoSmithKline drug during the first three months of pregnancy shows possible links to birth defects.
Adams Respiratory Therapeutics, Inc. announced that it has filed a lawsuit in the United States District Court for the District of New Jersey against Mutual Pharmaceuticals Co. and United Research Laboratories, Inc. (URL), both wholly owned subsidiaries of Pharmaceutical Holdings Corp. for infringement of U.S. Patent No. 6,372,252, issued in April 2002.
Gilead Sciences Inc., the world's third-biggest biotechnology company, said on Monday it agreed to acquire Myogen Inc. for $2.5 billion in a surprise transaction that gives Gilead access to Myogen's experimental hypertension drugs.
Pharmaceutical maker Bayer says it stands behind the safety of the drug Trasylol despite a U.S. warning it could increase the risk of stroke and even death.
Barr Pharmaceutical announced Sept. 28 that it is now free to close a deal with Shire, acquiring the rights to Shire's attention-deficit/hyperactivity disorder drug Adderall immediate-release (IR) tablets.
The FDA is seeking to help the pharma industry adopt modern quality management system principles so that companies can produce drugs more efficiently, lower costs and prevent shortages through a new guidance released Sept. 29.
The future of the Centers for Medicare & Medicaid Services' (CMS) plan to share prescription drug plan data with the FDA in an effort to base Medicare reimbursement on product comparisons is in doubt as the agency determines whether it has the legal authority to share this information, an industry source says.
People with kids who take prescription medication for attention deficit hyperactivity disorder (ADHD) are 10 times more likely to be taking an ADHD drug themselves, according to an analysis of U.S. prescription use.